Mdeon
ActiveSummary
Mdeon has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €260,551. Equity is growing by ~24% per year across the filed fiscal years. Its solvency ranks better than 95% of 942 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability84▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200,000 at 30 days acceptable
short-term debt: 0.1% and cash: 44.1% of total assets, and 0.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 82
Relative position
BE, all sectors
reference
Office administrative, office support and other business support activities (NACE 82)
about 37% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
99.9%
Return on assets
12.3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
134 d early
2024
23 d early
2023
15 d early
2022
70 d late
2021
68 d late
2020
88 d early
2019
119 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average on the deadline day; the sector median for financial year 2024 is 7 days before the deadline, and 35% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 17 July (4 of the last 5 filed years within 84 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€260,551▲ 8.1%
2024 · €241,116
Working capital
€1.8m▼ 0.6%
2024 · €1.8m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 82, Office administrative, office support and other business support activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€371,019€642,871▲ 73.3%€267,488▼ 58.4%€265,791▼ 0.6%€271,024▲ 2.0%
Net result€351,465above the sector's middle half€612,262above the sector's middle half▲ 74.2%€243,450above the sector's middle half▼ 60.2%€241,116above the sector's middle half▼ 1.0%€260,551within the sector's middle half▲ 8.1%
Equity€760,894within the sector's middle half▲ 85.8%€1.4mabove the sector's middle half▲ 80.5%€1.6mwithin the sector's middle half▲ 17.7%€1.9mwithin the sector's middle half▲ 14.9%€2.1mwithin the sector's middle half▲ 14.0%
Total assets€789,378within the sector's middle half▲ 79.6%€1.4mwithin the sector's middle half▲ 77.9%€1.6mwithin the sector's middle half▲ 16.0%€1.9mwithin the sector's middle half▲ 14.5%€2.1mwithin the sector's middle half▲ 13.7%
Debt€28,484▼ 5.2%€31,474▲ 10.5%€12,950▼ 58.9%€8,136▼ 37.2%€2,466▼ 69.7%
Working capital€764,939above the sector's middle half▲ 85.2%€1.4mabove the sector's middle half▲ 76.9%€1.6mabove the sector's middle half▲ 17.3%€1.8mabove the sector's middle half▲ 14.3%€1.8mabove the sector's middle half▼ 0.6%
Solvency96.4%above the sector's middle half▲ 3.2pp97.8%above the sector's middle half▲ 1.4pp99.2%above the sector's middle half▲ 1.4pp99.6%above the sector's middle half▲ 0.4pp99.9%above the sector's middle half▲ 0.3pp
Current ratio37.14above the sector's middle half▲ 15.8151.48above the sector's middle half▲ 14.34
Return on assets (ROA)44.5%above the sector's middle half▲ 65.7pp43.6%above the sector's middle half▼ 0.9pp14.9%above the sector's middle half▼ 28.6pp12.9%above the sector's middle half▼ 2.0pp12.3%above the sector's middle half▼ 0.6pp
Staff (FTE)0.8below the sector's middle half0.7below the sector's middle half▼ 12.5%
above
within
below
the middle half (P25 to P75) of NACE 82, Office administrative, office support and other business support activities, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
- 2023 Net result -60% on 2022. The accounts now follow the full schema, last year the abbreviated schema.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 2% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.1m
Fixed assets
€313,659 ▲ 637%
Current assets
€1.8m ▼ 0.9%
Equity and liabilities €2.1m
Equity
€2.1m ▲ 14.0%
Debt
€2,466 ▼ 69.7%
Debt's share of the balance-sheet total falls from 0.4% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€299,528▲
2024 · €287,346
Cash flow
€289,055▲
2024 · €262,671
Debt to equity
0.00▼
2024 · 0.00
ROE
12.3%▼
2024 · 13.0%
Interest coverage
9.93▼
2024 · 10.14
Debt ≤ 1 year
€2,197▼
2024 · €8,136
Income taxes
€5,614▲
2024 · €387
Staff costs
€63,687▲
2024 · €43,765
A ratio outside any meaningful range has been withheld (balance sheet total €2.1m, equity €2.1m).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,349 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.4%
went bankrupt
5.9%
stopped otherwise
93%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,349 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €3,059 | - | - |
| Remuneration, social security and pensions62 | €340 | €8,016 | €24,300 | €43,765 | €63,687 | ▲ 45.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,817 | €13,937 | €20,709 | €21,555 | €28,504 | ▲ 32.2% |
| Other operating charges640/8 | €637 | €639 | €709 | €7,858 | €6,904 | ▼ 12.1% |
| Non-recurring operating charges66A | - | - | - | €1,136 | €22,090 | ▲ 1,845% |
| Gross operating margin9900 | €374,813 | €665,463 | €313,207 | €340,104 | €392,209 | ▲ 15.3% |
| Operating profit (loss)9901 | €371,019 | €642,871 | €267,488 | €265,791 | €271,024 | ▲ 2.0% |
| Financial income75/76B | €0 | - | - | €4,053 | €25,312 | ▲ 525% |
| Recurring financial income75 | €0 | - | - | €4,053 | €25,312 | ▲ 525% |
| Financial charges65/66B | €19,554 | €30,609 | €24,038 | €28,341 | €30,171 | ▲ 6.5% |
| Recurring financial charges65 | €19,554 | €30,609 | €24,038 | €28,341 | €30,171 | ▲ 6.5% |
| Profit (loss) for the period before taxes9903 | €351,465 | €612,262 | €243,450 | €241,502 | €266,165 | ▲ 10.2% |
| Income taxes67/77 | - | - | - | €387 | €5,614 | ▲ 1,351% |
| Profit (loss) for the period9904 | €351,465 | €612,262 | €243,450 | €241,116 | €260,551 | ▲ 8.1% |
| Profit (loss) for the period to be appropriated9905 | €351,465 | €612,262 | €243,450 | €241,116 | €260,551 | ▲ 8.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €789,378 | €1.4m | €1.6m | €1.9m | €2.1m | ▲ 13.7% |
| Fixed assets21/28 | €3,274 | €24,261 | €30,762 | €42,556 | €313,659 | ▲ 637% |
| Intangible fixed assets21 | - | - | - | €23,797 | €141,451 | ▲ 494% |
| Tangible fixed assets22/27 | €2,296 | €23,284 | €29,785 | €17,782 | €171,231 | ▲ 863% |
| Furniture and vehicles24 | €2,296 | €23,284 | €29,785 | €9,073 | €11,618 | ▲ 28.0% |
| Other tangible fixed assets26 | - | - | - | €8,709 | €159,613 | ▲ 1,733% |
| Financial fixed assets28 | €977 | €977 | €977 | €977 | €977 | = |
| Current assets29/58 | €786,105 | €1.4m | €1.6m | €1.8m | €1.8m | ▼ 0.9% |
| Amounts receivable within one year40/41 | €8,917 | €14,818 | €19,045 | €57,372 | €79,385 | ▲ 38.4% |
| Trade receivables40 | €8,907 | €14,808 | €9,200 | €9,326 | €16,073 | ▲ 72.4% |
| Other amounts receivable41 | €10 | €10 | €9,845 | €48,046 | €63,312 | ▲ 31.8% |
| Current investments50/53 | - | - | - | €783,000 | €783,000 | = |
| Cash at bank and in hand54/58 | €767,019 | €1.4m | €1.6m | €971,048 | €934,511 | ▼ 3.8% |
| Deferred charges and accrued income490/1 | €10,169 | €9,467 | €9,894 | €11,881 | €10,184 | ▼ 14.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €789,378 | €1.4m | €1.6m | €1.9m | €2.1m | ▲ 13.7% |
| Equity10/15 | €760,894 | €1.4m | €1.6m | €1.9m | €2.1m | ▲ 14.0% |
| Reserves13 | €352,000 | €352,000 | €852,000 | €852,000 | €852,000 | = |
| Profit (loss) carried forward14 | €408,894 | €1.0m | €764,606 | €1.0m | €1.3m | ▲ 25.9% |
| Amounts payable17/49 | €28,484 | €31,474 | €12,950 | €8,136 | €2,466 | ▼ 69.7% |
| Amounts payable within one year42/48 | €21,165 | €26,815 | €10,832 | €8,136 | €2,197 | ▼ 73.0% |
| Trade debts44 | €8,551 | €13,207 | €7,144 | €4,999 | €1,649 | ▼ 67.0% |
| Suppliers440/4 | €8,551 | €13,207 | €7,144 | €4,999 | €1,649 | ▼ 67.0% |
| Taxes, remuneration and social security45 | €11,013 | €13,609 | €3,688 | €3,137 | €548 | ▼ 82.5% |
| Taxes450/3 | €11,013 | €12,854 | - | - | €19 | - |
| Remuneration and social security454/9 | - | €755 | €3,688 | €3,137 | €529 | ▼ 83.1% |
| Accrued charges and deferred income492/3 | €7,319 | €4,659 | €2,118 | - | €269 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €351,465 | €612,262 | €243,450 | €241,116 | €260,551 | ▲ 8.1% |
| + Depreciation and write-downs630 | €2,817 | €13,937 | €20,709 | €21,555 | €28,504 | ▲ 32.2% |
| Operating cash flow (approximation) | €354,283 | €626,198 | €264,160 | €262,671 | €289,055 | ▲ 10.0% |
| Investment in fixed assets (approximation) | - | -€34,924 | -€27,210 | -€33,349 | -€299,607 | ▼ 798% |
| Change in cash | - | €589,065 | €213,771 | -€598,806 | -€36,537 | ▲ 93.9% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-03
State Gazette act
Withdrawal: Axxon (member)Resignations: Belgische Vereniging van Artsensyndicaten (BVAS), vzw (director) and Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (director) · Appointments: Belgische Vereniging van Artsensyndicaten (BVAS), vzw, Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw and 6 others · Permanent representatives: Marc Léon, Katrien Hermans and 16 others55 facts ▸
State Gazette act
Withdrawal: Axxon (member)
Resignations: Belgische Vereniging van Artsensyndicaten (BVAS), vzw (director) and Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (director) · Appointments: Belgische Vereniging van Artsensyndicaten (BVAS), vzw, Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw and 6 others · Permanent representatives: Marc Léon, Katrien Hermans and 16 others55 facts ▸
- Board meeting, 16/12/2025
- General meeting, 16/12/2025
- Member resignation, Axxon
- Director resignation, Belgische Vereniging van Artsensyndicaten (BVAS), vzw (director)
- Director resignation, Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (director)
- Director discharge, Belgische Vereniging van Artsensyndicaten (BVAS), vzw
- Director discharge, Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw
- Director appointment, Belgische Vereniging van Artsensyndicaten (BVAS), vzw (director)
- Director appointment, Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (director)
- Permanent representative, Marc Léon
- Permanent representative, Katrien Hermans
- Director reappointment, Belgian Association of Consumer Healthcare Industry (BACHI) (director)
- +43 further facts in this act
19-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
19-03
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Liquidity quadruplescurrent ratio 822.62
Current ratio from 224.12 to 822.62; short-term debt falls from €8,136 to €2,197.
31-12
Financial
Equity above €2mEq €2.1m ▲14%
5 profitable years in a row build equity to €2.1m.
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Liquidity triplescurrent ratio 147.59
Current ratio from 51.48 to 147.59; short-term debt falls from €26,815 to €10,832.
09-10
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 70 days late
2022
31-12
Financial
Highest result since 2018net €612,262 ▲74.2%
Operating result €642,871, net result €612,262, both a record.
Show earlier events
31-12
Financial
Equity above €1mEq €1.4m ▲80.5%
2 profitable years in a row build equity to €1.4m.
07-10
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 68 days late
2021
31-12
Financial
Back to profitnet €351,465
Net result €351,465 after one loss-making year.
31-12
Financial
Equity above €500,000Eq €760,894 ▲85.8%
Equity rises from €409,429 to €760,894.
04-05
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Weakest financial yearnet -€93,242
Net result drops to -€93,242, the lowest in the series; recovery starts the following year.
27-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 119 days late
2019
31-12
Financial
Equity above €500,000Eq €502,670 ▲14.3%
2 profitable years in a row build equity to €502,670.
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.
2 of 44 acts read
About the unread acts
Of the 44 Belgian State Gazette acts we know for this company, 2 have been read. The other 42 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
28 directors, 12 in day-to-day management, last change in 2026
Board 28
Algemene Pharmaceutische Bond (APB), Koninklijke Maatschappij, Nationale Federatie van Belgische Apothekersverenigingen
CurrentDirector · Legal entity · perm. rep.: Nicolas Echement
Algemene Unie van Verpleegkundigen van België (AUVB), vzw
CurrentDirector · Legal entity · perm. rep.: Sigurd Vandendriessche
Association Pharmaceutique Belge (APB), Société royale, Fédération Nationale des Unions Professionnelles Pharmaceutiques, Union Professionnelle reconnue
CurrentDirector · Legal entity · perm. rep.: Nicolas Echement
Belgian Association of Consumer Healthcare Industry (BACHI)
CurrentDirector · Legal entity · perm. rep.: Marc Gryseels
Belgian Society of General Practitioners-Family Physicians (BSGP), asbl
CurrentDirector · Legal entity · perm. rep.: Sonya Goudjil
Belgian Society of General Practitioners-Family Physicians (BSGP), vzw
CurrentDirector · Legal entity · perm. rep.: Sonya Goudjil
beMedTech, asbl
CurrentDirector · Legal entity · perm. rep.: Koen Bruylant
beMedTech, vzw
CurrentDirector · Legal entity · perm. rep.: Koen Bruylant
Show all 28 directors
Confedération des Médecins belges ou Cartel (ASGB-GBO-SBGS/SBMS), asbl
CurrentDirector · Legal entity · perm. rep.: Roberto Salgado
Groupement des Unions Professionnelles Belges de Médecins Spécialistes (GBS), Union Profess. reconnue
CurrentDirector · Legal entity · perm. rep.: Marianne Michel
Instituut voor Permanente Studie voor Apothekers (IPSA), asbl
CurrentDirector · Legal entity · perm. rep.: Maurice Malfait
Instituut voor Permanente Studie voor Apothekers (IPSA), vzw
CurrentDirector · Legal entity · perm. rep.: Maurice Malfait
Konfederatie der Belgische Geneesheren of Kartel (ASGB-GBO-SBGS/SBMS), vzw
CurrentDirector · Legal entity · perm. rep.: Roberto Salgado
Office des Pharmacies Coopératives de Belgique (OPHACO), Union Professionnelle reconnue
CurrentDirector · Legal entity · perm. rep.: Paul Perdieus
pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie, vzw
CurrentDirector · Legal entity · perm. rep.: Olivia Geldof
pharma.be - Association Générale de l'Industrie du médicament, asbl
CurrentDirector · Legal entity · perm. rep.: Olivia Geldof
Société Scientifique des Pharmaciens Francophones (SSPF), asbl
CurrentDirector · Legal entity · perm. rep.: Marie-Françoise Barbay
Société Scientifique des Pharmaciens Francophones (SSPF), vzw
CurrentDirector · Legal entity · perm. rep.: Marie-Françoise Barbay
Syndicaat van Vlaamse Huisartsen (SVH), asbl
CurrentDirector · Legal entity · perm. rep.: Johan Brouns
Syndicaat van Vlaamse Huisartsen (SVH), vzw
CurrentDirector · Legal entity · perm. rep.: Johan Brouns
Union Générale des Infirmières de Belgique (UGIB), asbl
CurrentDirector · Legal entity · perm. rep.: Sigurd Vandendriessche
Union Professionnelle des Vétérinaires (UPV), asbl
CurrentDirector · Legal entity · perm. rep.: Benoit Roelants
Union Professionnelle des Vétérinaires (UPV), vzw
CurrentDirector · Legal entity · perm. rep.: Benoit Roelants
Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS), Wettelijk Erkende Beroepsvereniging
CurrentDirector · Legal entity · perm. rep.: Marianne Michel
Vereniging der Coöperatieve Apotheken van België (OPHACO), Erkende Beroepsvereniging
CurrentDirector · Legal entity · perm. rep.: Paul Perdieus
Vlaamse Beroepsvereniging Tandartsen (VBT), Wettelijk Erkende Beroepsvereniging
CurrentDirector · Legal entity · perm. rep.: Philippe Versluysen
Vlaamse Vereniging van Ziekenhuisinstrumentatietechnici vzw
CurrentDirector · Legal entity · perm. rep.: Gunter Groenen
Zorgnet Icuro vzw
CurrentDirector · Legal entity · perm. rep.: Vera De Toyer
Day-to-day management 12
Algemene Unie van Verpleegkundigen van België (AUVB), vzw
CurrentDay-to-day manager · since 16-12-2025 · Legal entity · perm. rep.: Sigurd Vandendriessche
Belgian Association of Consumer Healthcare Industry (BACHI)
CurrentDay-to-day manager · since 16-12-2025 · Legal entity · perm. rep.: Marc Gryseels
beMedTech, vzw
CurrentDay-to-day manager · since 16-12-2025 · Legal entity · perm. rep.: Koen Bruylant
Mieke GOOSSENS
CurrentDay-to-day manager · since 16-12-2025
pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie, vzw
CurrentDay-to-day manager · since 16-12-2025 · Legal entity · perm. rep.: Olivia Geldof
Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS), Wettelijk Erkende Beroepsvereniging
CurrentDay-to-day manager · since 16-12-2025 · Legal entity · perm. rep.: Marianne Michel
Association Belge des Syndicats Médicaux (Absym), asbl
CurrentDay-to-day manager · since 23-03-2026 · Legal entity
beMedTech, asbl
CurrentDay-to-day manager · since 23-03-2026 · Legal entity · perm. rep.: Koen Bruylant
Show all 12 office holders
Fédération des entreprises belges de médicaments génériques (Medaxes/FeBelGen), asbl
CurrentDay-to-day manager · since 23-03-2026 · Legal entity
Groupement des Unions Professionnelles Belges de Médecins Spécialistes (GBS), Union Profess. reconnue
CurrentDay-to-day manager · since 23-03-2026 · Legal entity · perm. rep.: Marianne Michel
pharma.be - Association Générale de l'Industrie du médicament, asbl
CurrentDay-to-day manager · since 23-03-2026 · Legal entity · perm. rep.: Olivia Geldof
Union Générale des Infirmières de Belgique (UGIB), asbl
CurrentDay-to-day manager · since 23-03-2026 · Legal entity · perm. rep.: Sigurd Vandendriessche
Permanent representatives 16
Benoit Roelants
CurrentPermanent representative · for Union Professionnelle des Vétérinaires (UPV), asbl
Gunter Groenen
CurrentPermanent representative · for Vlaamse Vereniging van Ziekenhuisinstrumentatietechnici vzw
Johan Brouns
CurrentPermanent representative · for Syndicaat van Vlaamse Huisartsen (SVH), asbl
Koen Bruylant
CurrentPermanent representative · for beMedTech, asbl
Marc Gryseels
CurrentPermanent representative · for Belgian Association of Consumer Healthcare Industry (BACHI)
Marianne Michel
CurrentPermanent representative · for Groupement des Unions Professionnelles Belges de Médecins Spécialistes (GBS), Union Profess. reconnue
Marie-Françoise Barbay
CurrentPermanent representative · for Société Scientifique des Pharmaciens Francophones (SSPF), asbl
Maurice Malfait
CurrentPermanent representative · for Instituut voor Permanente Studie voor Apothekers (IPSA), asbl
Show all 16 representatives
Nicolas Echement
CurrentPermanent representative · for Algemene Pharmaceutische Bond (APB), Koninklijke Maatschappij, Nationale Federatie van Belgische Apothekersverenigingen
Olivia Geldof
CurrentPermanent representative · for pharma.be - Association Générale de l'Industrie du médicament, asbl
Paul Perdieus
CurrentPermanent representative · for Office des Pharmacies Coopératives de Belgique (OPHACO), Union Professionnelle reconnue
Philippe Versluysen
CurrentPermanent representative · for Vlaamse Beroepsvereniging Tandartsen (VBT), Wettelijk Erkende Beroepsvereniging
Roberto Salgado
CurrentPermanent representative · for Confedération des Médecins belges ou Cartel (ASGB-GBO-SBGS/SBMS), asbl
Sigurd Vandendriessche
CurrentPermanent representative · for Union Générale des Infirmières de Belgique (UGIB), asbl
Sonya Goudjil
CurrentPermanent representative · for Belgian Society of General Practitioners-Family Physicians (BSGP), asbl
Vera De Toyer
CurrentPermanent representative · for Zorgnet Icuro vzw
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
42 of this company's 44 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Machelen (Brab.) · 1 establishment unit since 2007
Ground area
3.4 ha
Building footprint
2,592 m²
Volume, LiDAR
39,191 m³
Parcel 23015B0090/00L000, Flanders · tallest building 28.3 m, ±7 floors. Linked by address, not a title deed.
8
companies at this address
See who is registered here
1 establishment unit
Mdeon
since 20072.160.996.979
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23015B0090/00L000 | Flanders | 3.4 ha | 2 · 2,592 m² | 28.3 m · 7 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
33 people since 2025, 31 in office
- Board
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| Algemene Unie van Verpleegkundigen van België (AUVB), vzw |
|
| Belgian Association of Consumer Healthcare Industry (BACHI) |
|
| beMedTech, vzw |
|
| pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie, vzw |
|
| Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS), Wettelijk Erkende Beroepsvereniging |
|
| Algemene Pharmaceutische Bond (APB), Koninklijke Maatschappij, Nationale Federatie van Belgische Apothekersverenigingen |
|
| Association Pharmaceutique Belge (APB), Société royale, Fédération Nationale des Unions Professionnelles Pharmaceutiques, Union Professionnelle reconnue |
|
| Belgian Society of General Practitioners-Family Physicians (BSGP), asbl |
|
| Belgian Society of General Practitioners-Family Physicians (BSGP), vzw |
|
| beMedTech, asbl |
|
| Confedération des Médecins belges ou Cartel (ASGB-GBO-SBGS/SBMS), asbl |
|
| Groupement des Unions Professionnelles Belges de Médecins Spécialistes (GBS), Union Profess. reconnue |
|
| Instituut voor Permanente Studie voor Apothekers (IPSA), asbl |
|
| Instituut voor Permanente Studie voor Apothekers (IPSA), vzw |
|
| Konfederatie der Belgische Geneesheren of Kartel (ASGB-GBO-SBGS/SBMS), vzw |
|
| Office des Pharmacies Coopératives de Belgique (OPHACO), Union Professionnelle reconnue |
|
| pharma.be - Association Générale de l'Industrie du médicament, asbl |
|
| Société Scientifique des Pharmaciens Francophones (SSPF), asbl |
|
| Société Scientifique des Pharmaciens Francophones (SSPF), vzw |
|
| Syndicaat van Vlaamse Huisartsen (SVH), asbl |
|
| Syndicaat van Vlaamse Huisartsen (SVH), vzw |
|
| Union Générale des Infirmières de Belgique (UGIB), asbl |
|
| Union Professionnelle des Vétérinaires (UPV), asbl |
|
| Union Professionnelle des Vétérinaires (UPV), vzw |
|
| Vereniging der Coöperatieve Apotheken van België (OPHACO), Erkende Beroepsvereniging |
|
| Vlaamse Beroepsvereniging Tandartsen (VBT), Wettelijk Erkende Beroepsvereniging |
|
| Vlaamse Vereniging van Ziekenhuisinstrumentatietechnici vzw |
|
| Zorgnet Icuro vzw |
|
| Association Belge des Syndicats Médicaux (Absym), asbl |
|
| Fédération des entreprises belges de médicaments génériques (Medaxes/FeBelGen), asbl |
|
| Mieke GOOSSENS |
|
| Belgische Federatie van producenten van Generische Geneesmiddelen (Medaxes), vzw |
|
| Belgische Vereniging van Artsensyndicaten (BVAS), vzw |
|
Structure & network
Connections & network
31 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Recognitions · licences · registrations
Legal Entity Identifier
984500014E88A953K438
Similar companies · same sector, comparable size
Parojo
BE 0667.711.079
Antwerpen · Eq €2,120,040
Shell EV Charging Solutions Belgium
BE 0699.495.902
Brussel · Eq €2,120,219
Holiday Inns of Belgium
BE 0406.137.218
Brussel · Eq €2,113,862
GEVAN
BE 0871.691.290
Mol · Eq €2,123,836
GEKAPLUS
BE 0597.774.871
Grobbendonk · Eq €2,112,600
Of 24,517 companies in sector 82990 we hold annual accounts for 9,421. 3,123 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formNon-profit association
Founded29-06-2006
Fiscal year end31-12
Activities, NACEBEL 2025
82990Other business support services
94110Activities of business and employers' organisations
Contact
Website
www.mdeon.be
E-mail
secretariaat@mdeon.be
E-invoicing
Reachable via Peppol
Peppol ID
0208:0882170755
Also
9925:BE0882170755
Registered
30-01-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.